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Abstract
Activation of Th1 or Th2 cells is associated with production of
specific immunoglobulin isotypes, offering the opportunity to use
antibody measurement for evaluation of T cell function. Schistoso-
miasis and visceral leishmaniasis are diseases associated with Th2
activation. However, an IgE response is not always detected in these
patients. In the present study we evaluated specific IgE antibodies to S.
mansoni and L. chagasi antigens by ELISA after depletion of serum
IgG with protein G immobilized on Sepharose beads or RF-absorbent
(purified sheep IgG antibodies anti-human IgG). In schistosomiasis
patients, specific IgE to SWAP antigen was demonstrable in only 10 of
21 patients (48%) (mean absorbance – SD = 0.102 – 0.195) when
unabsorbed serum was used. Depletion of IgG with protein G in-
creased the number of specific IgE-positive tests to 13 (62%) and the
use of RF-absorbent increased the number of positive results to 20
(95%) (mean absorbances – SD = 0.303 – 0.455 and 0.374 – 0.477,
respectively). Specific IgE anti-L. chagasi antibodies were not de-
tected in unabsorbed serum from visceral leishmaniasis patients.
When IgG was depleted with protein G, IgE antibodies were detected
in only 3 (11%) of 27 patients, and the use of RF-absorbent permitted
the detection of this isotype in all 27 visceral leishmaniasis sera tested
(mean absorbance – SD = 0.104 – 0.03). These data show that the
presence of IgG antibodies may prevent the detection of a specific IgE
response in these parasite diseases. RF-absorbent, a reagent that
blocks IgG-binding sites and also removes rheumatoid factor, was
more efficient than protein G for the demonstration of specific IgE
antibodies.
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IgE production is dependent on IL-4, a
cytokine involved in differentiation of CD4+
Th2 cells (1). Since IL-4 is also one of the
main cytokines secreted by Th2 cells, deter-
mination of total IgE or antigen-specific IgE
has been used to determine the occurrence of
Th2 activation in several clinical conditions
including autoimmune and parasite diseases
(2,3). Although the IgE isotype is mainly
associated with allergic reactions classified
as type I hypersensitivity (4), its relationship
to infectious diseases such as helminthiasis
(5) and more recently with protozoan and
viral infections has been demonstrated (3,5).
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In these conditions, the demonstration of
specific IgE antibodies has been used for the
diagnosis of toxoplasmosis (6) and total IgE
production has been used as a marker of
disease severity in malaria and HIV infec-
tion (7-10).
Although assays to detect allergen-spe-
cific IgE antibodies in sera have been stan-
dardized, these procedures cannot be ap-
plied to detect antigen-specific IgE antibod-
ies in patients with diseases associated with
polyclonal B cell activation and hypergam-
maglobulinemia. In such cases, false-nega-
tive results may occur due to IgG antibody
competition for the same epitopes. In the
present study we tested the efficacy of previ-
ous depletion of IgG with protein G or puri-
fied sheep IgG anti-human IgG in immu-
noassays to facilitate the demonstration of
antigen-specific IgE antibodies in serum of
patients with schistosomiasis and visceral
leishmaniasis.
Schistosoma mansoni soluble antigens
were obtained from adult worms of the Puerto
Rico strain. Briefly, adult worms were disin-
tegrated with a sonicator and centrifuged at
100,000 g for 45 min to obtain clear superna-
tants corresponding to the soluble antigen
(SWAP). Protein concentration was deter-
mined by the method of Bradford (11).
Leishmania chagasi antigens were pre-
pared from 109 stationary phase promasti-
gotes grown in LIT medium supplemented
with 10% fetal calf serum, RPMI 1640
(Gibco, Grand Island, NY, USA) and gen-
tamicin. The promastigotes were washed 3
times with phosphate-buffered saline (PBS)
and lysed with 6 mM CHAPS (3-[(3-
cholanidopropyl)-dimethyl-ammonio]-1 pro-
pane sulfonate) in 50 mM Tris-HCl buffer
containing 150 mM NaCl, pH 7.5. After
centrifugation at 13,000 g for 5 min the
protein content was measured by the method
of Bradford (11) and stored at -20oC until
use.
Twenty-one sera from patients with schis-
tosomiasis and 27 sera from patients with
visceral leishmaniasis were screened for the
presence of specific IgE antibodies. Patients
with visceral leishmaniasis were admitted to
Hospital UniversitÆrio Prof. Edgard Santos
or Hospital Santo Antônio (Salvador, BA,
Brazil). They presented with the classical
clinical picture of visceral leishmaniasis and
the diagnosis was confirmed by demonstra-
tion of amastigote forms in material obtained
from bone marrow or spleen aspiration and
stained with Giemsa. IgG antibodies were
also detected by ELISA in all patients (12).
The schistosomiasis patients were from the
endemic area of Caatinga do Moura, Bahia,
and had S. mansoni eggs in their stools. They
suffered from chronic schistosomiasis in its
intestinal or hepato-intestinal form.
IgE antibodies against S. mansoni were
investigated by indirect ELISA performed
on wells of polystyrene microtiter plates pre-
viously coated with 4 µg protein of SWAP.
The tests were performed with unabsorbed
sera diluted 1:10 in PBS containing 0.05%
Tween. In order to eliminate competition
from IgG antibodies, immunoassays were
also performed with 100 µl of serum diluted
1:10 in PBS containing 25% Sepharose-pro-
tein G (Pharmacia, Uppsala, Sweden) or pu-
rified sheep IgG anti-human immunoglobu-
lin IgG (RF-absorbent; Behring Diagnostics,
Marburg, Germany) previously reconstituted
to 1.5 ml. After centrifugation to remove the
Sepharose beads or immunoprecipitates, all
primary reactions were developed with 100
µl of the supernatants for 18 h at 4oC, whereas
secondary reactions were carried out with
100 µl of peroxidase-conjugated mouse mon-
oclonal anti-human IgE (Medix Biotech, Inc.,
Miami, FL, USA) for 1 h at 37oC. The immu-
noassays were developed with 100 µl of
sodium acetate buffer containing TMB
(3,3’,5,5tetramethylbenzidine) and H2O2 for
30 min at room temperature, and the absor-
bances of the reactions were measured at
450-600 nm with an ELISA reader after the
addition of 50 µl of 2 N HCl.
Anti-leishmania-specific IgE in sera from
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visceral leishmaniasis and control subjects
were also investigated by indirect ELISA
performed as described above, using 500 ng
of L. chagasi antigen, and patient sera were
diluted 1:6 in PBS containing protein G or
RF-absorbent. Specific leishmania antigens
recognized by the IgE antibodies from pa-
tient sera were identified by Western immu-
noblotting (13). For these experiments, 500
µl of visceral leishmaniasis or control sera
was previously depleted of human IgG by
diluting the sera 1:5 in PBS with 25% (v/v)
protein G Sepharose.
The cut-offs of the immunoassays were
determined using the mean plus 3 SD of the
absorbance obtained with serum from 10
healthy individuals. Specificity and sensitiv-
ity were determined as recommended by
Ferreira and `vila (14). The computer pro-
gram GRAPHPAD was used for statistical
analysis.
IgE antibodies anti-S. mansoni were de-
tected in only 10 (48%) of 21 patients when
unabsorbed sera were used in the immu-
noassays. Depletion of IgG by treatment with
protein G beads increased the number of
positive sera to 13 (62%) and the use of RF-
absorbent allowed the detection of specific
IgE antibodies in 20 (95%) of 21 positive
sera (Figure 1). Mean absorbance (– SD)
was 0.108 – 0.195 when the unabsorbed sera
were used. These values were 0.303 – 0.455
in sera depleted of IgG using protein G and
0.374 – 0.477 in sera pre-absorbed with RF-
absorbent (P<0.01).
Specific IgE antibodies anti-L. chagasi
were not detected when whole serum from
visceral leishmaniasis patients was used in
the ELISA. After IgG depletion with protein
G, IgE antibodies were detected in 3 (11%)
of 27 sera and the use of RF-absorbent in-
creased the detection of IgE antibodies to all
sera tested (100%) (Figure 2). Mean absorb-
ance (– SD) was 0.104 – 0.03 when sera
depleted of IgG with RF-absorbent were used
in the ELISA. Western immunoblotting was
performed with sera from three patients with
visceral leishmaniasis. The IgE antibodies
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Figure 1 - Detection of specific
IgE antibodies anti-S. mansoni
(Sm) by ELISA with unabsorbed
sera and sera treated with pro-
tein G or RF-absorbent from 21
S. mansoni patients. The cut-off
is the mean ± 3 SD of 10 sera
from healthy subjects.
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predominantly recognized antigens with
molecular masses of 96.67 and 46 kDa. Due
to the limited amount of sera available, West-
ern immunoblotting was also performed with
pooled sera from 5 other patients and a simi-
lar antigen recognition pattern was obtained.
The present study describes a simple
method to detect specific IgE antibodies in
patients with two different parasite diseases,
both of them associated with hyperglobu-
linemia and evidence of Th2 activation (15-
17). In schistosomiasis there is an increase in
IgE production and higher levels of specific
IgE against parasite antigens and IgE:IgG4
ratios are significantly associated with a lower
intensity of re-infection (18,19). In a previ-
ous study on schistosomiasis conducted in
Africa, IgE antibodies were detected directly
in unabsorbed sera (20). The present study
shows that the sensitivity of detection of
SWAP-specific IgE is low when unabsorbed
sera are used, whereas the use of RF-absorb-
ent facilitated the detection of IgE antibodies
in up to 95% of the schistosomiasis patients.
Visceral leishmaniasis is associated with
high mRNA for IL-4 and Th2 activation.
Since this cytokine signals B cells to pro-
duce IgE (1) and previous studies have shown
high levels of total IgE in visceral leishman-
iasis, we determined the levels of L. chagasi-
specific IgE in patients with this disease.
When unabsorbed sera were used, ELISA
failed to detect L. chagasi-specific IgE,
whereas the inhibition of IgG by RF-absorb-
ent permitted the detection of IgE in all
patients tested.
Depletion of IgG antibodies by protein G
has been previously used to rule out the
blocking effect of IgG in serological tests
(18). In the present study, protein G and RF-
absorbent were compared and RF-absorbent
was found to increase the sensitivity of the
test, facilitating detection of specific IgE
antibodies in the majority of schistosomiasis
patients and in all visceral leishmaniasis sera
tested. Two reasons might explain the rela-
tively low effectiveness of protein G. First,
in both conditions studied there are very
high IgG levels and even when using protein
G the sera from patients with visceral leish-
maniasis continue to contain up to 60% IgG.
Second, IgG antibodies against IgE are de-
tected in situations where polyclonal activa-
tion is observed (21). In such case, the use of
protein G may deplete the IgE that is com-
plexed with the IgG, decreasing the sensitiv-
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Figure 2 - Detection of specific
IgE antibodies anti-L. chagasi by
ELISA in sera from 27 visceral
leishmaniasis patients pre-
treated with protein G or RF-ab-
sorbent. The cut-off is the mean
± 3 SD of 10 sera from healthy
subjects.
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ity of detection of IgE antibodies. RF-ab-
sorbent is not very effective in removing
IgG. Its main function is to block the IgG-
binding sites, efficiently reducing the reac-
tion of IgG with the antigens and allowing
the detection of IgE antibodies.
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